Clinical Trials Logo

Renal Insufficiency, Chronic clinical trials

View clinical trials related to Renal Insufficiency, Chronic.

Filter by:

NCT ID: NCT02119832 Completed - Clinical trials for Chronic Kidney Disease (CKD)

A Prospective Clinical Evaluation of the Total Vascular Access (TVA) FLEX-1 Device Protocol Flex-1-002-IR Intervention Reduction (IR)

Start date: April 2013
Phase: N/A
Study type: Interventional

The primary objective of this clinical study is to evaluate the preliminary safety and effectiveness of using the FLEX-1 device for the creation of an arteriovenous fistula (AVF) including coiling of the brachial vein during the index procedure in patients requiring chronic hemodialysis.

NCT ID: NCT02117427 Completed - Clinical trials for Chronic Kidney Disease

TARGTEPO Treatment for Anemia in Chronic Kidney Disease (CKD) Patients and End-Stage Renal Disease (ESRD)

Start date: May 27, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The objectives of this study are to assess safety and to evaluate the biologic activity of TARGTEPO treatment.

NCT ID: NCT02116270 Completed - Renal Failure Clinical Trials

Accelerated Immunosenescence and Chronic Kidney Disease

IRIS
Start date: September 2013
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the impact of renal function and dialysis techniques on the percentage of senescent T lymphocytes.

NCT ID: NCT02114281 Completed - Clinical trials for Chronic Kidney Disease

Oral and Dental Health Status in Patients Suffering From Chronic Kidney Disease

NEPHRODENT
Start date: September 16, 2014
Phase: N/A
Study type: Interventional

A large panel of oral and dental diseases exist in patients suffering from chronic kidney disease (CKD) in end-stage renal disease: it concerns teeth, peridontium, alveolar bone and saliva and it has been already described in the literature. The consequences of oral diseases in systemic health are substantial, including increase of inflammatory parameters, alteration of nutrition and increase of cardiovascular risk factors. It has been shown before that several oral diseases can be considered as cardiovascular risk factor in the general population and in diabetic patients through the chronic inflammatory pathway. In CKD patients, the influence of oral diseases on the progression of the chronic kidney disease is not yet established, as most of the studies are focused on stage 5 CKD or dialysis patients. That's why the interactions between dental health and CKD will be evaluated in this population of patients, at different stages of the disease (stages 2 to 5). The main objective will be to describe the oral diseases at each stage of CKD. Secondary objectives will be: (1) To evaluate the link between the oral health and the chronic kidney disease stage, the nutritional and inflammatory status; (2) Among patients needing dental treatments, to evaluate after 6 months and 12 months whether dental cares have an influence on nutrition parameters, inflammatory status and CKD; (3) to evaluate the completion of dental treatments after the dental consultation including advises on dental health.

NCT ID: NCT02113462 Completed - Clinical trials for Chronic Kidney Disease

Triglyceride/High-density Lipoprotein Cholesterol Ratio in Chronic Kidney Disease

Start date: January 2009
Phase: N/A
Study type: Observational

The Triglycerides (TG) to High Density Lipoprotein Cholesterol (HDL-C) ratio is a feature of insulin resistance and an independent predictor of cardiovascular risk. The investigators aimed to evaluate the relationship between TG/HDL-C ratio and the endothelial functions in patients with CKD.

NCT ID: NCT02112825 Completed - Clinical trials for Focus Chronic Kidney Disease With Hypertension

Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease

PACE
Start date: July 2013
Phase: N/A
Study type: Interventional

The general objective of the study is to investigate the effect of regular aerobic exercise on resting and 24-hr blood pressure levels in men and women with stage 3-4 kidney disease and hypertension.

NCT ID: NCT02112071 Completed - Clinical trials for Focus Type 2 Diabetes Related Chronic Kidney Disease

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.

DKD-EXT
Start date: October 2009
Phase: N/A
Study type: Interventional

The general objective is to investigate the effect of a 12 week walking exercise program on vascular endothelial function, arterial stiffness/compliance, and vascular health biomarkers in men and women with pre-dialysis type 2 diabetic kidney disease (DKD).

NCT ID: NCT02110901 Completed - Clinical trials for Chronic Kidney Disease

A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)

Start date: July 2014
Phase: Phase 3
Study type: Interventional

This research study is designed to assess the safety and effectiveness of an experimental drug called PRT-201 in patients both receiving or expecting to receive dialysis who have chronic kidney disease and who are undergoing surgery to create a new access point to their bloodstream for hemodialysis. PRT-201 is a protein that has been shown in previous research studies to help keep vessels patent when applied to the outside surface of the blood vessels (arteries and veins) in patients who undergo surgery to create an arteriovenous fistula (AVF). The purpose of this study is to determine whether PRT-201 when applied to a limited segment of your blood vessel (about 2 inches) immediately after surgery is safe and improves the patency of your AVF.

NCT ID: NCT02103556 Completed - Clinical trials for Chronic Kidney Disease

Edible Oils in the Treatment of Constipation of Hemodialysis Patients

Start date: April 2012
Phase: N/A
Study type: Interventional

The purpose of this study was to evaluate the effect of olive oil and flaxseed oil in the treatment of constipation of patients undergoing hemodialysis.

NCT ID: NCT02102204 Completed - Clinical trials for Hyperparathyroidism, Secondary

Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis

Start date: March 25, 2014
Phase: Phase 3
Study type: Interventional

This is a multicenter, single-arm, extension study to characterize the long-term safety and tolerability of etelcalcetide in the treatment of Secondary Hyperparathyroidism (SHPT) in adults with Chronic Kidney Disease (CKD) on hemodialysis.